Incomplete response - major depressive disorder (ir-MDD)

Clinical trials for Incomplete response - major depressive disorder (ir-MDD) explained in plain language.

Never miss a new study

Get alerted when new Incomplete response - major depressive disorder (ir-MDD) trials appear

Sign up with your email to follow new studies for Incomplete response - major depressive disorder (ir-MDD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Brain scan study tests new Drug's target binding in healthy volunteers

Knowledge-focused Stopped early

This early-stage study involves 18 healthy men to see how well the experimental drug MSP-2020 attaches to serotonin receptors in the brain. Researchers will also measure how much drug stays in the blood and check for side effects. The goal is to understand the drug's activity in …

Matched conditions: INCOMPLETE RESPONSE - MAJOR DEPRESSIVE DISORDER (IR-MDD)

Phase 1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused

Last updated Aug 20, 2026 00:00 UTC

Incomplete response - major depressive disorder (ir-MDD)

Get alerted when new Incomplete response - major depressive disorder (ir-MDD) trials appear

Brain scan study tests new Drug's target binding in healthy volunteers